Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-015294

President and CEO acquired 335,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Valamehr Bahram President and CEO 2026-01-15 Grant or award +335,000 664,708 D
Derivatives
Valamehr Bahram President and CEO 2026-01-15 Grant or award · Stock Option (Right to Buy) +1,300,000 1,300,000 D
Loading xslF345X05/ownership.xml…